Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Pulmonary Hypertension

Free Subscription 14.01.2019 2 Am J Physiol Heart Circ Physiol 12 Am J Physiol Lung Cell Mol Physiol 1 Ann Am Thorac Soc 1 Arterioscler Thromb Vasc Biol 1 Biomed Res Int 1 Circ Heart Fail 1 Circulation 1 Eur J Intern Med 1 FASEB J 2 Front Cardiovasc Med 1 Front Physiol 1 Health Phys 1 Int J Cardiol 1 Int J Cardiovasc Imaging 1 J Biomech 1 J Cardiothorac Vasc Anesth 1 J Cardiovasc Imaging 1 J Perinatol 1 JACC Basic Transl Sci 1 Minerva Cardioangiol 1 Pediatr Emerg Care 1 Pediatr Neonatol 1 Radiographics 1 Semin Cardiothorac Vasc Anesth 1 Sheng Li Xue Bao 1 Ther Adv Respir Dis 1 Thorax 1 Transpl Int 1 Transplant Proc 1 Vascul Pharmacol 1 World J Pediatr

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Physiol Heart Circ Physiol

1. WEISE-CROSS L, Sands MA, Sheak JR, Broughton BRS, et al
   Actin polymerization contributes to enhanced pulmonary vasoconstrictor reactivity after chronic hypoxia.
   Am J Physiol Heart Circ Physiol. 2018;314:H1011-H1021.
   PubMed     Text format     Abstract available
   
   
2. DE WIJS-MEIJLER DPM, van Duin RWB, Duncker DJ, Scherrer U, et al
   Structural and functional changes of the pulmonary vasculature after hypoxia exposure in the neonatal period: a new swine model of pulmonary vascular disease.
   Am J Physiol Heart Circ Physiol. 2018;314:H603-H615.
   PubMed     Text format     Abstract available
   
   

   
   Am J Physiol Lung Cell Mol Physiol

3. ZHANG R, Su H, Ma X, Xu X, et al
   MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2.
   Am J Physiol Lung Cell Mol Physiol. 2019 Jan 10. doi: 10.1152/ajplung.00387.2018
   PubMed     Text format     Abstract available
   
   
4. CHAUDHARY KR, Stewart DJ
   Go with the (back) flow: what can retrograde perfusion teach us about arterial remodeling in pulmonary arterial hypertension?
   Am J Physiol Lung Cell Mol Physiol. 2018;314:L797-L798.
   PubMed     Text format    
   
   
5. YADAV VR, Song T, Mei L, Joseph L, et al
   PLCgamma1-PKCepsilon-IP3R1 signaling plays an important role in hypoxia-induced calcium response in pulmonary artery smooth muscle cells.
   Am J Physiol Lung Cell Mol Physiol. 2018;314:L724-L735.
   PubMed     Text format     Abstract available
   
   
6. SURESH K, Servinsky L, Jiang H, Bigham Z, et al
   Reactive oxygen species induced Ca(2+) influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.
   Am J Physiol Lung Cell Mol Physiol. 2018;314:L893-L907.
   PubMed     Text format     Abstract available
   
   
7. LU Q, Gottlieb E, Rounds S
   Effects of cigarette smoke on pulmonary endothelial cells.
   Am J Physiol Lung Cell Mol Physiol. 2018;314:L743-L756.
   PubMed     Text format     Abstract available
   
   
8. ZHOU C, Crockett ES, Batten L, McMurtry IF, et al
   Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.
   Am J Physiol Lung Cell Mol Physiol. 2018;314:L835-L845.
   PubMed     Text format     Abstract available
   
   
9. YEE M, Cohen ED, Domm W, Porter GA Jr, et al
   Neonatal hyperoxia depletes pulmonary vein cardiomyocytes in adult mice via mitochondrial oxidation.
   Am J Physiol Lung Cell Mol Physiol. 2018;314:L846-L859.
   PubMed     Text format     Abstract available
   
   
10. BARRETO ORTIZ S, Hori D, Nomura Y, Yun X, et al
    Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L93-L106.
    PubMed     Text format     Abstract available
    
    
11. SYSOL JR, Chen J, Singla S, Zhao S, et al
    Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L461-L472.
    PubMed     Text format     Abstract available
    
    
12. LI HH, Hsu HH, Chang GJ, Chen IC, et al
    Prostanoid EP4 agonist L-902,688 activates PPARgamma and attenuates pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L349-L359.
    PubMed     Text format     Abstract available
    
    
13. BLISSENBACH B, Nakas CT, Kronke M, Geiser T, et al
    Hypoxia-induced changes in plasma micro-RNAs correlate with pulmonary artery pressure at high altitude.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L157-L164.
    PubMed     Text format     Abstract available
    
    
14. SUZUKI T, Carrier EJ, Talati MH, Rathinasabapathy A, et al
    Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2018;314:L118-L126.
    PubMed     Text format     Abstract available
    
    

    
    Ann Am Thorac Soc

15. THAYER TE, Huang S, Levinson RT, Farber-Eger E, et al
    Unbiased Phenome-wide Association Studies of Red Cell Distribution Width Identifies Key Associations with Pulmonary Hypertension.
    Ann Am Thorac Soc. 2019 Jan 4. doi: 10.1513/AnnalsATS.201809.
    PubMed     Text format     Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

16. ZHU L, Xiao R, Zhang X, Lang Y, et al
    Spermine on Endothelial Extracellular Vesicles Mediates Smoking-Induced Pulmonary Hypertension Partially Through Calcium-Sensing Receptor.
    Arterioscler Thromb Vasc Biol. 2019 Jan 10:ATVBAHA118312280.
    PubMed     Text format     Abstract available
    
    

    
    Biomed Res Int

17. HE Q, Nan X, Li S, Su S, et al
    Tsantan Sumtang Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Inhibiting Proliferation of Pulmonary Vascular Cells.
    Biomed Res Int. 2018;2018:9504158.
    PubMed     Text format     Abstract available
    
    

    
    Circ Heart Fail

18. HSU S
    Coupling Right Ventricular-Pulmonary Arterial Research to the Pulmonary Hypertension Patient Bedside.
    Circ Heart Fail. 2019;12:e005715.
    PubMed     Text format    
    
    

    
    Circulation

19. 
    Correction to: Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
    Circulation. 2019;139:e1.
    PubMed     Text format    
    
    

    
    Eur J Intern Med

20. JOPPI R, Gerardi C, Bertele' V, Garattini S, et al
    A disease looking for innovative drugs: The case of pulmonary arterial hypertension.
    Eur J Intern Med. 2018;55:47-51.
    PubMed     Text format     Abstract available
    
    

    
    FASEB J

21. NEUMANN V, Knies R, Seidinger A, Simon A, et al
    The beta2 agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via alpha adrenoceptor antagonism.
    FASEB J. 2018;32:2519-2530.
    PubMed     Text format     Abstract available
    
    

    
    Front Cardiovasc Med

22. VISWANATHAN G, Mamazhakypov A, Schermuly RT, Rajagopal S, et al
    The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension.
    Front Cardiovasc Med. 2018;5:179.
    PubMed     Text format     Abstract available
    
    
23. CHEONG HI, Farha S, Park MM, Thomas JD, et al
    Endothelial Phenotype Evoked by Low Dose Carvedilol in Pulmonary Hypertension.
    Front Cardiovasc Med. 2018;5:180.
    PubMed     Text format     Abstract available
    
    

    
    Front Physiol

24. KARMOUTY-QUINTANA H, Guignabert C, Kwapiszewska G, Ormiston ML, et al
    Editorial: Molecular Mechanisms in Pulmonary Hypertension and Right Ventricle Dysfunction.
    Front Physiol. 2018;9:1777.
    PubMed     Text format    
    
    

    
    Health Phys

25. JACOBS ER, Narayanan J, Fish BL, Gao F, et al
    Cardiac Remodeling and Reversible Pulmonary Hypertension During Pneumonitis in Rats after 13-Gy Partial-Body Irradiation with Minimal Bone Marrow Sparing: Effect of Lisinopril.
    Health Phys. 2019 Jan 8. doi: 10.1097/HP.0000000000000919.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cardiol

26. WIEDENROTH CB
    Multimodality treatment for chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2018 Dec 29. pii: S0167-5273(18)36195.
    PubMed     Text format    
    
    

    
    Int J Cardiovasc Imaging

27. HAMATANI Y, Amaki M, Yonezawa R, Yanagi Y, et al
    Prevalence, determinants, and prognostic significance of exercise-induced pulmonary hypertension in patients with hypertrophic cardiomyopathy.
    Int J Cardiovasc Imaging. 2019 Jan 8. pii: 10.1007/s10554-018-01522.
    PubMed     Text format     Abstract available
    
    

    
    J Biomech

28. ZAMBRANO BA, McLean NA, Zhao X, Tan JL, et al
    Image-based computational assessment of vascular wall mechanics and hemodynamics in pulmonary arterial hypertension patients.
    J Biomech. 2018;68:84-92.
    PubMed     Text format     Abstract available
    
    

    
    J Cardiothorac Vasc Anesth

29. ELHASSAN A, Essandoh M
    Inhaled Levosimendan for Pulmonary Hypertension Treatment During Cardiac Surgery: A Novel Application to Avoid Systemic Hypotension.
    J Cardiothorac Vasc Anesth. 2018 Nov 28. pii: S1053-0770(18)31091.
    PubMed     Text format    
    
    

    
    J Cardiovasc Imaging

30. SEO HS, Lee H
    Assessment of Right Ventricular Function in Pulmonary Hypertension with Multimodality Imaging.
    J Cardiovasc Imaging. 2018;26:189-200.
    PubMed     Text format     Abstract available
    
    

    
    J Perinatol

31. ALTIT G, Bhombal S, Hopper RK, Tacy TA, et al
    Death or resolution: the "natural history" of pulmonary hypertension in bronchopulmonary dysplasia.
    J Perinatol. 2019 Jan 7. pii: 10.1038/s41372-018-0303.
    PubMed     Text format     Abstract available
    
    

    
    JACC Basic Transl Sci

32. TANG H, Wu K, Wang J, Vinjamuri S, et al
    Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2018;3:744-762.
    PubMed     Text format     Abstract available
    
    

    
    Minerva Cardioangiol

33. DE VECCHIS R, Cesaro A, Ariano C
    Differential effects of the phosphodiesterase inhibition in chronic heart failure depending on the echocardiographic phenotype (HFREF or HFpEF): a meta-analysis.
    Minerva Cardioangiol. 2018;66:659-670.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Emerg Care

34. NOORBAKHSH KA, Bell-Cheddar YR, Marin JR
    Focused Cardiac Ultrasound in Pediatric Pulmonary Hypertension.
    Pediatr Emerg Care. 2019 Jan 7. doi: 10.1097/PEC.0000000000001700.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Neonatol

35. YUAN SM
    Pulmonary artery hypertension in childhood: The transforming growth factor-beta superfamily-related genes.
    Pediatr Neonatol. 2018;59:112-119.
    PubMed     Text format     Abstract available
    
    

    
    Radiographics

36. MORADI F, Morris TA, Hoh CK
    Perfusion Scintigraphy in Diagnosis and Management of Thromboembolic Pulmonary Hypertension.
    Radiographics. 2019;39:169-185.
    PubMed     Text format     Abstract available
    
    

    
    Semin Cardiothorac Vasc Anesth

37. LOMBARD FW, Liang Y
    Perioperative Risk Factors for Mitral Valve Surgery: Atrial Fibrillation and Pulmonary Hypertension.
    Semin Cardiothorac Vasc Anesth. 2019 Jan 4:1089253218821694.
    PubMed     Text format    
    
    

    
    Sheng Li Xue Bao

38. YU FY, Yang SC, Ji ES
    [The role of adventitia in hypoxic vascular remodeling].
    Sheng Li Xue Bao. 2018;70:211-216.
    PubMed     Text format     Abstract available
    
    

    
    Ther Adv Respir Dis

39. COONS JC, Miller T
    Extended-release oral treprostinil in the management of pulmonary arterial hypertension: clinical evidence and experience.
    Ther Adv Respir Dis. 2018;12:1753466618766490.
    PubMed     Text format     Abstract available
    
    

    
    Thorax

40. MILARA J, Ballester B, Morell A, Ortiz JL, et al
    JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study.
    Thorax. 2018;73:519-529.
    PubMed     Text format     Abstract available
    
    

    
    Transpl Int

41. WEBER U, Schiefer J, Muhlbacher J, Bernardi MH, et al
    High altitude trekking after lung transplantation: a prospective study using lung ultrasound to detect comets tails for interstitial pulmonary edema in lung transplant recipients and healthy volunteers.
    Transpl Int. 2018;31:1245-1253.
    PubMed     Text format     Abstract available
    
    

    
    Transplant Proc

42. UENO T, Hiwatashi S, Saka R, Yamanaka H, et al
    Pulmonary Arterial Pressure Management Based on Oral Medicine for Pediatric Living Donor Liver Transplant With Portopulmonary Hypertension.
    Transplant Proc. 2018 Mar 15. pii: S0041-1345(18)30401.
    PubMed     Text format     Abstract available
    
    

    
    Vascul Pharmacol

43. WANG J, Tian XT, Peng Z, Li WQ, et al
    HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
    Vascul Pharmacol. 2019 Jan 2. pii: S1537-1891(18)30358.
    PubMed     Text format     Abstract available
    
    

    
    World J Pediatr

44. YE LF, Fan Y, Shu Q, Lin R, et al
    Management of persistent pulmonary hypertension in newborns with ECMO support: a single center's experience.
    World J Pediatr. 2019 Jan 3. pii: 10.1007/s12519-018-0215.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: